Losartan Potassium
Product Images NDC 75921-409
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 75921-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Life Line Home Care Services, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula (Losartanpotassiumusp Figure 01)
Image (Losartanpotassiumusp Figure 02)
This appears to be a graph displaying the percentage of patients with a primary endpoint for two medications, atenolol and losartan potassium tablets, over the course of a 66-month study. The adjusted risk reduction for losartan over atenolol is 13%, with a p-value of 0.021. The text above the graph is not legible and contains some non-English characters.*
Image (Losartanpotassiumusp Figure 03)
This is a comparative study evaluating the effect of Atenolol and Losartan Potassium Tablets on patients with fatal/non-fatal stroke. The study reports an adjusted risk reduction of 25% for patients treated with Losartan Potassium Tablets, with a p-value of 0.001. The graph suggests that the risk reduction was observed over a period of 60 months, with measurements taken at regular intervals.*
Image (Losartanpotassiumusp Figure 04)
Image (Losartanpotassiumusp Figure 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.